HRP20080243T3 - 4-(2-fenilsulfanil-fenil)-1,2,3,6-tetrahidropiridin derivati kao serotonin za inhibiciju ponovne apsorpcije - Google Patents

4-(2-fenilsulfanil-fenil)-1,2,3,6-tetrahidropiridin derivati kao serotonin za inhibiciju ponovne apsorpcije

Info

Publication number
HRP20080243T3
HRP20080243T3 HR20080243T HRP20080243T HRP20080243T3 HR P20080243 T3 HRP20080243 T3 HR P20080243T3 HR 20080243 T HR20080243 T HR 20080243T HR P20080243 T HRP20080243 T HR P20080243T HR P20080243 T3 HRP20080243 T3 HR P20080243T3
Authority
HR
Croatia
Prior art keywords
alk
cycloalk
hydrogen
independently selected
yloxy
Prior art date
Application number
HR20080243T
Other languages
English (en)
Inventor
Pschl Ask
Bang-Andersen Benny
Jorgensen Morten
Juhl Karsten
Ruhland Thomas
Andersen Kim
Kehler Jan
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35432910&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20080243(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of HRP20080243T3 publication Critical patent/HRP20080243T3/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Spoj naznačen time da je prikazan općom formulom Iu kojoj suR1, R2, R3, R4, R5 neovisno odabrani iz vodika, halogena, cijana, C1-6-alk(en/in)ila, C1-6-alk(en/in)iloksi, C1-6-alk(en/in)ilsulfanila, hidroksi, hidroksi-C1-6-alk(en/in)ila, halo-C1-6-alk(en/in)ila, halo-C1-6-alk(en/in)iloksi ili NRXRY gdje su RX i RY neovisno odabrani iz vodika, C1-6-alk(en/in)ila, C3-8-cikloalk(en)ila, C3-8-cikloalk(en)il-C1-6-alk(en/in)ila ili NRZRW gdje su RZ i RW neovisno odabrani iz vodika, C1-6-alk(en/in)ila, C3-8-cikloalk(en)ila ili C3-8-cikloalk(en)il-C1-6-alk(en/in)ila; ili RX i RY zajedno s dušikom na koji su vezani tvore 3-7-člani prsten koji opcionalno sadrži još jedan heteroatom; iliR2 i R3 zajedno tvore heteroprsten kondenziran na fenilni prsten odabran iza R1, R4, R5 su definirani kao gore; R6, R7, R8, R9 su neovisno odabrani iz vodika, halogena, C1-6-alk(en/in)ila, C1-6-alk(en/in)iloksi, C1-6-alk(en/in)ilsulfanila, hidroksi, hidroksi-C1-6-alk(en/in)ila, halo-C1-6-alk(en/in)ila, halo-C1-6-alk(en/in)iloksi ili NRXRY gdje RX i RY neovisno odabrani iz vodika, C1-6-alk(en/in)ila, C3-8-cikloalk(en)ila, C3-8-cikloalk(en)il-C1-6-alk(en/in)ila ili NRZRW-C1-6-alk(en/in)ila, gdje su RZ i RW neovisno odabrani iz vodika, C1-6-alk(en/in)ila,
HR20080243T 2003-04-04 2008-06-03 4-(2-fenilsulfanil-fenil)-1,2,3,6-tetrahidropiridin derivati kao serotonin za inhibiciju ponovne apsorpcije HRP20080243T3 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46026603P 2003-04-04 2003-04-04
DKPA200300518 2003-04-04
PCT/DK2004/000243 WO2004087662A1 (en) 2003-04-04 2004-04-02 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors

Publications (1)

Publication Number Publication Date
HRP20080243T3 true HRP20080243T3 (hr) 2009-04-30

Family

ID=35432910

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20080243T HRP20080243T3 (hr) 2003-04-04 2008-06-03 4-(2-fenilsulfanil-fenil)-1,2,3,6-tetrahidropiridin derivati kao serotonin za inhibiciju ponovne apsorpcije

Country Status (28)

Country Link
US (1) US20070173522A1 (hr)
EP (1) EP1613594B1 (hr)
JP (1) JP2006522029A (hr)
KR (1) KR20060021825A (hr)
CN (1) CN100384822C (hr)
AR (1) AR043964A1 (hr)
AT (1) ATE390413T1 (hr)
AU (1) AU2004226319A1 (hr)
BR (1) BRPI0408453A (hr)
CA (1) CA2521172A1 (hr)
CL (1) CL2004000730A1 (hr)
CO (1) CO5700777A2 (hr)
DE (1) DE602004012724T2 (hr)
DK (1) DK1613594T3 (hr)
EA (1) EA009282B1 (hr)
ES (1) ES2301979T3 (hr)
HK (1) HK1090051A1 (hr)
HR (1) HRP20080243T3 (hr)
IS (1) IS8007A (hr)
MX (1) MXPA05010678A (hr)
NO (1) NO20055205L (hr)
NZ (1) NZ541944A (hr)
PL (1) PL1613594T3 (hr)
PT (1) PT1613594E (hr)
SI (1) SI1613594T1 (hr)
UA (1) UA81300C2 (hr)
WO (1) WO2004087662A1 (hr)
ZA (1) ZA200507182B (hr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE406894T1 (de) 2003-04-04 2008-09-15 Lundbeck & Co As H 4-(2-phenylsulfanyl-phenyl)-piperidin-derivate als serotonin-wiederaufnahme-hemmer
EP2248524A3 (en) 2004-08-25 2011-03-09 Takeda Pharmaceutical Company Limited Preventives/remedies for stress urinary incontinence and method of screening the same
EP2742936A1 (en) 2006-05-16 2014-06-18 Takeda Pharmaceutical Company Limited Fused heterocyclic compound and use thereof
US20100266504A1 (en) 2007-11-15 2010-10-21 Takahiro Matsumoto Condensed pyridine derivative and use thereof
UA98698C2 (en) * 2008-03-03 2012-06-11 Х. Луннбек А/С Phenylsulfanylphenyl-piperidines and process for the preparation thereof
EP2510949A4 (en) 2009-12-11 2013-11-13 Astellas Pharma Inc THERAPEUTICS FOR FIBROMYALGIA
EP2930171A1 (en) * 2014-04-07 2015-10-14 LEK Pharmaceuticals d.d. Synthesis of vortioxetine via (2,4-dimethylphenyl)(2-iodophenyl)sulfane intermediate
CN105294554B (zh) * 2015-11-18 2017-11-07 乳源瑶族自治县大众药品贸易有限公司 苯基哌嗪衍生物及其使用方法和用途
EP3733204A4 (en) 2017-12-27 2021-09-15 Takeda Pharmaceutical Company Limited THERAPEUTIC FOR EXERCISE INCONTINENCE AND STAIR INCONTINENCE

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803143A (en) * 1969-09-08 1974-04-09 Eisai Co Ltd 6-amino alkylene 6,7-dihydro-5h-dibenzo (b,g),(1,5)thiazocines
US4018830A (en) * 1969-09-22 1977-04-19 Merck & Co., Inc. Phenylthioaralkylamines
US4055665A (en) * 1974-11-25 1977-10-25 Merck & Co., Inc. Treating arrythmia with phenylthioaralkylamines
US4066654A (en) * 1975-04-16 1978-01-03 G. D. Searle & Co. 1-triarylalkyl-4-phenyl-4-piperidine carboxylic acids and derivatives
US4056632A (en) * 1975-07-21 1977-11-01 Burroughs Wellcome Co. 2-Hydroxymethyl-2'-aminomethyl-diphenylsulfides and method of use
US4241071A (en) * 1977-01-27 1980-12-23 American Hoechst Corporation Antidepressant (α-phenyl-2-tolyl)azacycloalkanes
DE2802306A1 (de) * 1977-01-27 1978-08-10 Hoechst Ag Azacycloalkane, azacycloalkene und ihre derivate
US4198417A (en) * 1979-01-10 1980-04-15 American Hoechst Corporation Phenoxyphenylpiperidines
US4198419A (en) * 1979-01-10 1980-04-15 American Hoechst Corporation Phenylthiophenylpiperidines
GB8912971D0 (en) * 1989-06-06 1989-07-26 Wellcome Found Halogen substituted diphenylsulfides
GEP20043160B (en) * 1999-10-13 2004-01-26 Pfizer Products Inc Us Biaryl Ether Derivatives, Pharmaceutical Compositions Containing Them and Their Use as Monoamine Reuptake Inhibitors
US6410736B1 (en) * 1999-11-29 2002-06-25 Pfizer Inc. Biaryl ether derivatives useful as monoamine reuptake inhibitors
PT1246816E (pt) * 1999-12-30 2004-08-31 Lundbeck & Co As H Derivados de fenilpiperazina substituidos sua preparacao e utilizacao
US6436938B1 (en) * 2001-01-22 2002-08-20 Pfizer Inc. Combination treatment for depression
US20020107244A1 (en) * 2001-02-02 2002-08-08 Howard Harry R. Combination treatment for depression
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну

Also Published As

Publication number Publication date
EP1613594B1 (en) 2008-03-26
JP2006522029A (ja) 2006-09-28
CL2004000730A1 (es) 2005-02-18
SI1613594T1 (sl) 2008-08-31
NO20055205L (no) 2005-11-04
CN100384822C (zh) 2008-04-30
MXPA05010678A (es) 2005-12-12
EA009282B1 (ru) 2007-12-28
US20070173522A1 (en) 2007-07-26
EA200501579A1 (ru) 2006-04-28
ZA200507182B (en) 2006-12-27
WO2004087662A1 (en) 2004-10-14
CO5700777A2 (es) 2006-11-30
CA2521172A1 (en) 2004-10-14
KR20060021825A (ko) 2006-03-08
EP1613594A1 (en) 2006-01-11
IS8007A (is) 2005-08-29
BRPI0408453A (pt) 2006-04-04
CN1777585A (zh) 2006-05-24
ATE390413T1 (de) 2008-04-15
PL1613594T3 (pl) 2008-09-30
DE602004012724D1 (de) 2008-05-08
HK1090051A1 (en) 2006-12-15
AU2004226319A1 (en) 2004-10-14
DE602004012724T2 (de) 2009-04-09
ES2301979T3 (es) 2008-07-01
AR043964A1 (es) 2005-08-17
DK1613594T3 (da) 2008-07-14
UA81300C2 (en) 2007-12-25
PT1613594E (pt) 2008-07-01
NZ541944A (en) 2008-05-30

Similar Documents

Publication Publication Date Title
HRP20080243T3 (hr) 4-(2-fenilsulfanil-fenil)-1,2,3,6-tetrahidropiridin derivati kao serotonin za inhibiciju ponovne apsorpcije
AR049739A1 (es) Derivados de aril-piridina
NO20092770L (no) Nye aminopyrimidinderivater som PLK1-inhibitorer
RS52865B (en) Phenyl-piperazine Derivatives As Serotonin Resorption Inhibitors
CR7950A (es) Sintesis de los cloruros de 4amino -2butenoilo y su uso en la preparacion of 3- cianoquinolinas
CO5640049A2 (es) Inhibidores de fluor y trifluoroalquilo que contienen inhibidores de sulfonamieda heterociclicos de la produccion beta amiloide y derivados de los mismos
DE60335869D1 (de) 1h-benzo(f)indazol-5-yl-derivate als selektive glucocorticoid-rezeptor-modulatoren
ECSP088549A (es) Nuevos derivados de pirrol fusionado
CO5721006A2 (es) Derivados de pirazolo-quinazolina, proceso para su preparacion y su uso como inhibidores de quinasa
CY1110651T1 (el) Παραγωγα της ν-'(1,5-διφαινυλ-1η- πυραζολ-3-υλ)μεθυλ σουλφοναμιδης με μια συγγενεια για τους υποδοχεις cb1
TW200505834A (en) Sulfamide derivative and the pharmaceutical composition thereof
TW200724136A (en) Pharmaceutical compositions comprising PPAR modulator
ATE503746T1 (de) Neue imidazolidinderivate
WO2009095792A3 (en) Substituted heteroarylamide diazepinopyrimidone derivatives
CO5601030A2 (es) Derivados de quinolinona/benzoxazinona y usos de los mismos
NO970349L (no) Forbindelser som er anvendbare som antiproliferative midler og GARFT inhibitorer
MXPA05007341A (es) Derivados de 2-piperidona como agonistas de prostaglandina.
WO2008136444A1 (ja) 縮合複素環誘導体
AR039988A1 (es) Derivados de benzoxazina como moduladores de 5-ht6 y usos de los mismos
DE602004020730D1 (de) Pharmazeutisches verfahren und damit hergestellte verbindungen
CO5660263A2 (es) Derivados de imidazol heteroaril sustituidos como antagonistas del receptor de glutamato
DK1893589T3 (da) Substituerede N-benzo[d]isoxazol-3-yl-amin-derivater som inhibitorer af mGluR5-, serotonin-(5-HT) og noradrenalinreceptorer og deres anvendelse til fremstilling af lægemidler
EA200700246A1 (ru) Трициклические производные пиразола в качестве модуляторов каннабиноидного рецептора
TNSN05291A1 (en) Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors
ATE447575T1 (de) Selektive spirocyclische glucocorticoid-rezeptor- modulatoren